Ketamine is not a reset button. It is a neuroplastic window. When administered under careful psychiatric supervision as part of a comprehensive treatment architecture, ketamine assisted psychotherapy can facilitate emotional processing and neural reorganization that years of standard treatment could not produce. At Dr. Williams Source Psychiatry™ in Austin, Texas, ketamine therapy is never offered in isolation. It is integrated into a broader evaluation and treatment plan. That distinction matters.
If standard treatment has not produced the depth of change you need, you may request evaluation
Call to book an appointment (512) 766-3061 or fill out the form below.
The ketamine therapy landscape has expanded rapidly. Clinics offering ketamine infusions without psychiatric evaluation have proliferated. The model is often: arrive, receive an infusion, leave. No psychiatric assessment. No integration. No understanding of what the ketamine is being asked to do within the patient’s specific clinical picture.
That model treats ketamine as a product. I treat it as a clinical tool within a psychiatric framework.
In my practice, ketamine assisted psychotherapy begins with comprehensive psychiatric evaluation. The clinical picture must justify the intervention. The patient’s biological variables, medication interactions, trauma history, and treatment goals must be assessed before ketamine is considered. This is not gatekeeping. This is clinical precision.
I recommend ketamine assisted psychotherapy for patients with treatment resistant depression, anxiety, or PTSD who have undergone adequate trials of standard treatment without sufficient response. Patients whose clinical picture suggests that neuroplastic facilitation could accelerate therapeutic progress. Patients who are prepared for the depth of work that integration requires.
This is not for patients seeking a quick experience or a shortcut around the work of treatment. Ketamine creates a window. The patient must be willing to do the work that window makes possible.
If you have been partially treated for years and suspect that standard approaches have reached their ceiling. If you are drawn to this kind of intervention and are prepared for the depth it requires. You may request evaluation. I maintain a small patient roster. Not all inquiries can be accommodated. That is by design.
Dr. Williams Source Psychiatry™ is located at Wild Basin II, 108 Wild Basin Rd S Suite 250, Austin, TX 78746. If you are seeking ketamine therapy in Austin, Texas under the direct supervision of a board certified psychiatrist who integrates ketamine into comprehensive treatment architecture, Dr. Williams Source Psychiatry™ offers this level of care. You may request evaluation by calling (512) 766-3061 or completing the intake form.
This comparison shows how an integrated psychiatric model may differ from ketamine treatment focused mainly on the medicine session. It does not compare Source Psychiatry™ with a specific clinic or provider.
| Care area | Source Psychiatry™ Ketamine Assisted Psychotherapy | Session-Only Ketamine Care |
|---|---|---|
| Initial assessment | Begins with a comprehensive psychiatric evaluation and review of the patient’s broader clinical history. | Assessment may focus primarily on eligibility and medical safety for ketamine treatment. |
| Treatment approach | Ketamine is incorporated into an individualized psychiatric treatment plan. | Ketamine may be provided mainly as a standalone treatment session. |
| Medical screening | Reviews cardiovascular health, medications, substance use, psychiatric stability, and possible contraindications. | Screening may be limited to the information needed to determine whether the session can proceed safely. |
| Preparation | Includes treatment goals, informed consent, grounding strategies, expectations, and readiness for the experience. | Preparation may focus more on procedural instructions and session logistics. |
| Medicine session | Sessions generally last two to two and a half hours, with conservative dosing and direct physician support in a controlled setting. | Session duration, dosing, setting, and level of clinician involvement can vary. |
| Integration | Follow-up integration helps connect insights from the session with ongoing psychiatric care and daily life. | Integration may be optional, handled by another professional, or not included. |
| Patient selection | Considered for selected patients with treatment-resistant depression, anxiety, or PTSD who have completed appropriate standard treatment trials. | Eligibility may rely mainly on diagnosis, prior treatment response, and basic medical screening. |
Treatment is individualized, and ketamine assisted psychotherapy is not appropriate for every patient. Completing an evaluation does not guarantee acceptance into treatment.
Key facts from a 2024 clinical review in American Family Physician
Treatment-resistant depression (TRD) can occur in up to 31% of patients with major depressive disorder.
Ketamine or esketamine may be considered as an augmentation treatment option for appropriate patients with TRD.
TRD is generally defined as depression that has not reached remission after:
